Luciferase Reporter Cell Line - BeWo

BeWo is a human trophoblast-derived cell line established from a choriocarcinoma of placental origin and is widely used as an in vitro model for studying human placental biology. Because BeWo cells retain many functional and biochemical characteristics associated with trophoblasts, they are commonly applied to research on placental development, hormone production, nutrient transport, cell differentiation, and maternal-fetal interface mechanisms. Luciferase Reporter Cell Line - BeWo refers to a genetically engineered BeWo cell model that stably carries a luciferase reporter construct designed to convert specific biological signals into a measurable luminescent output. Compared with conventional endpoint assays, luciferase reporter BeWo cells provide a rapid, reproducible, and dynamic readout that can be detected using a luminometer or plate reader after addition of an appropriate luciferase substrate.

Luciferase Reporter Cell Line - BeWo can be used in a broad range of cell-based applications related to placental toxicology, endocrine disruption, drug evaluation, molecular signaling, and gene regulation. In reproductive and developmental toxicology, this cell line can help assess how pharmaceutical compounds, environmental chemicals, nanoparticles, pesticides, food contaminants, or cosmetic ingredients influence trophoblast-associated signaling pathways or promoter activities. Since the placenta is a key barrier and endocrine organ during pregnancy, BeWo-based reporter assays are valuable for studying potential effects on placental function, including trophoblast differentiation, syncytialization-related signaling, inflammatory responses, oxidative stress pathways, and hormone-regulated transcription. In drug discovery and safety pharmacology, the reporter system enables quantitative evaluation of candidate molecules for their ability to activate or inhibit specific cellular pathways, supporting dose-response analysis, compound ranking, and early toxicity screening.